Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1109)	2/8/1999 6:13:00 PM
From: Bindusagar Reddy	Read Replies (3) \| Respond to of 2539

Here are some numbers I gathered by researching JP Morgan and ML reports. Total prescriptions through 2/5/99 was 139,000. On 2/5/99 alone 16,900 scripts written. First week 5000. Second week 1/29/99 was 45,800 That means they had 88,200 prescriptions during week of 2/5/99. That is astounding. This is second only to Viagra in history of all drug launches. Remember they have not officially launched any marketing. They will in 3rd week of Feb. From what I hear the patient feedback is excellant. It works great with no side effects.. Next week will be interesting for MTC. BR

To: Anthony Wong who wrote (1109)	2/8/1999 6:14:00 PM
From: Rob C.	Respond to of 2539

I think the arbs are shorting MTC, DLP's price has stabilzed....I think the specialist has been holding DLP down because of the sudden jump in MTC. Why should they let the stock go if there is no demand. The thing that makes me laugh is that the merger is on course, but because of the AHP collapse, people are not willing to buy DLP stock(the risk reward isn't there). I am long both, I can't see selling DLP at 33, if the merger goes through, I get 39 and change. Meanwhile I sell calls, the 35's usually and collect nice monthly premiums. If anyone reading these boards can stop DLP from closing above $35.00 on Feb 20th, it would be much appreciated. Regards to all, Rob